A streamlined pipeline for multiplexed quantitative site-specific N-glycoproteomics.
Pan FangYanlong JiIvan SilbernCarmen DoebeleMomchil NinovChristof LenzThomas OellerichKuan-Ting PanHenning UrlaubPublished in: Nature communications (2020)
Regulation of protein N-glycosylation is essential in human cells. However, large-scale, accurate, and site-specific quantification of glycosylation is still technically challenging. We here introduce SugarQuant, an integrated mass spectrometry-based pipeline comprising protein aggregation capture (PAC)-based sample preparation, multi-notch MS3 acquisition (Glyco-SPS-MS3) and a data-processing tool (GlycoBinder) that enables confident identification and quantification of intact glycopeptides in complex biological samples. PAC significantly reduces sample-handling time without compromising sensitivity. Glyco-SPS-MS3 combines high-resolution MS2 and MS3 scans, resulting in enhanced reporter signals of isobaric mass tags, improved detection of N-glycopeptide fragments, and lowered interference in multiplexed quantification. GlycoBinder enables streamlined processing of Glyco-SPS-MS3 data, followed by a two-step database search, which increases the identification rates of glycopeptides by 22% compared with conventional strategies. We apply SugarQuant to identify and quantify more than 5,000 unique glycoforms in Burkitt's lymphoma cells, and determine site-specific glycosylation changes that occurred upon inhibition of fucosylation at high confidence.
Keyphrases
- mass spectrometry
- high resolution
- multiple sclerosis
- ms ms
- liquid chromatography
- high performance liquid chromatography
- capillary electrophoresis
- gas chromatography
- induced apoptosis
- single cell
- electronic health record
- emergency department
- computed tomography
- diffuse large b cell lymphoma
- tandem mass spectrometry
- cell proliferation
- signaling pathway
- amino acid
- oxidative stress
- bioinformatics analysis
- cell cycle arrest
- drug induced
- artificial intelligence
- pi k akt